Cipla Limited: Basic Information
Full Name: Cipla Limited
Type: Public Sector Pharmaceutical Company
Headquarters: Mumbai, Maharashtra, India
Founded: 1935
Founder: Khwaja Abdul Hamied
Chairman: YK Hamied (as of 2025)
CEO & MD: Umang Vohra (as of 2025)
Tagline: Caring for Life
Industry: Pharmaceuticals and Healthcare
Products and Services:
- Therapeutic Areas: Respiratory, cardiovascular, oncology, and anti-infectives
- Generic Drugs: High-quality and affordable medicines
- Specialty Products: Biologics, inhalation therapy, and critical care drugs
- Consumer Healthcare: Over-the-counter (OTC) products and wellness solutions
Key Financial Metrics (as of 2024):
- Revenue: ₹26,000 crore (approx.)
- Net Profit: ₹4,000 crore (approx.)
- Market Capitalization: ₹90,000 crore (approx.)
Global Presence:
- Operations in over 80 countries
- Manufacturing facilities in India, South Africa, and North America
- Strong export portfolio, serving key markets like the US, Europe, and Africa
Recognition:
- Pioneer in making medicines affordable globally
- Known for innovations in inhalation therapy and biosimilars
- Recognized for its sustainability initiatives and ethical practices
Cipla Limited is a leading pharmaceutical company committed to providing affordable and high-quality healthcare solutions. Established in 1935 and headquartered in Mumbai, Cipla has been at the forefront of the global fight against life-threatening diseases with its wide range of therapeutic products. The company is a pioneer in respiratory care, oncology, and anti-infectives, offering both generic and specialty medicines. With state-of-the-art manufacturing facilities and a robust R&D pipeline, Cipla caters to millions of patients across more than 80 countries.
Similar to Reliance’s impact on energy and telecom, Cipla has revolutionized the healthcare industry by making life-saving drugs accessible and affordable worldwide. Its focus on innovation, patient-centric solutions, and sustainability underscores its commitment to improving lives. As a trusted name in pharmaceuticals, Cipla continues to lead the way in addressing global healthcare challenges with cutting-edge therapies and a compassionate approach.